Abstract

Bcl-2 is a cytoplasmic integral membrane protein with potent anti-apoptotic activity but whose mechanism of action is poorly understood. The purpose of this paper was to obtain large amounts of soluble Bcl-2 protein for structural and functional studies. Mouse Bcl-2(1-203) (missing the COOH-terminal hydrophobic tail) was produced in bacterial inclusion bodies, solubilized in guanidine, and refolded by dialysis. The resulting protein was monomeric in nondenaturing solution and was active in protecting mouse T hybridoma cells from glucocorticoid-induced apoptosis. Refolded Bcl-2(1-203) showed no tendency to homodimerize by gel filtration or analytical ultracentrifugation. Limited proteolysis experiments identified a region between the BH3 and BH4 homology domains of Bcl-2(1-203) which was extremely susceptible to digestion by several common proteases, but not by a cell extract known to contain CPP-32-like (interleukin-1beta-converting enzyme family) protease activity. The protease-sensitive sites were located within a 50-residue stretch that contained most of the nonconserved and proline residues of Bcl-2(1-203). Trypsin-cleaved Bcl-2(1-203) eluted in the same position as the undigested protein on gel filtration in nondenaturing solution, indicating that the two portions of the molecule connected by the protease-sensitive region associate stably and noncovalently. The solution properties of Bcl-2(1-203) suggest that it consists of two noncovalently associated domains connected by a long protease-sensitive linker and that its structure is similar to that of Bcl-xL, which has been determined by x-ray and NMR analysis.

Highlights

  • From the ‡Experimental Immunology Branch and §Laboratory of Immune Cell Biology, NCI, National Institutes of Health, Bethesda, Maryland 20892-1360

  • Subsequent work indicated that overexpression of Bcl-2 prolonged cell survival (2) and inhibited programmed cell death induced by multiple, diverse stimuli including growth factor withdrawal, glucocorticoids, and ␥-irradiation (3, 4)

  • The flexible domain corresponds to a region of the Bcl-xL and Bcl-2 molecules which exhibits the greatest variability in amino acid sequence between molecules from different species and Bcl-2 family members

Read more

Summary

Introduction

From the ‡Experimental Immunology Branch and §Laboratory of Immune Cell Biology, NCI, National Institutes of Health, Bethesda, Maryland 20892-1360. Limited proteolysis experiments identified a region between the BH3 and BH4 homology domains of Bcl-2(1–203) which was extremely susceptible to digestion by several common proteases, but not by a cell extract known to contain CPP-32-like (interleukin-1␤-converting enzyme family) protease activity. Trypsincleaved Bcl-2(1–203) eluted in the same position as the undigested protein on gel filtration in nondenaturing solution, indicating that the two portions of the molecule connected by the protease-sensitive region associate stably and noncovalently. The solution properties of Bcl-2(1–203) suggest that it consists of two noncovalently associated domains connected by a long protease-sensitive linker and that its structure is similar to that of Bcl-xL, which has been determined by x-ray and NMR analysis. Bcl-2 heterodimerizes with the pro-apoptotic protein Bax, resulting in enhanced cell survival (9, 12). Unlike the BH1– 4 regions, the flexible domain can be deleted without loss of anti-apoptotic activity (7, 15)

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.